Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1Leukemia, Hairy Cell 1Inflammatory Breast Neoplasms 1Fibrosis 1Esophageal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2sofosbuvir-velpatasvir drug combination 1navitoclax 1hepatitis B hyperimmune globulin 1adefovir dipivoxil 1Sorafenib 1Simvastatin 1Lamivudine 1High-Energy Shock Waves 1Erlotinib Hydrochloride 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Fibrosis × High-Energy Shock Waves × Clear all
NCT03278925 2024-08-02

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

National Cancer Institute (NCI)

Phase 1 Active not recruiting
14 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡